Outcomes with metabolic surgery versus glucagon-like peptide-1 receptor agonists in patients with diabetes and obesity
Posted 20 Feb 2026
Dr Lisa Devine presents the findings from an observational study which compared the efficacy of metabolic surgery with that of glucagon-like peptide-1 receptor agonists for patients with diabetes and obesity.
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.